Joint Service Chemical & Biological Defense Program Overview ...

More documents

Recommendations

Info

Preface In 1993, Congress passed Public Law 103-160, Section 1703, which created a Joint Service Chemical and Biological Defense Program (CBDP). The mission of the CBDP is to provide world-class chemical and biological defense capabilities to allow the military forces of the United States to survive and successfully complete their operational missions — from peacetime contingency missions through two nearly simultaneous major theater wars across the entire spectrum of conflict—in battlespace environments contaminated with chemical or biological warfare agents. Under the oversight of a single office within the Office of the Secretary of Defense, the Deputy Assistant to the Secretary of Defense for Chemical and Biological Defense, the individual Services, working within the framework of a Joint Service Agreement, have planned and supported a robust, coordinated program. This overview document provides highlights of our major efforts within the program, providing a summary of FY00 accomplishments and goals for FY01 and beyond. A separate, more detailed DoD Annual Report to Congress on the Chemical and Biological Defense Program is provided to the Congress. The CBDP focuses on the development and acquisition of an integrated system-of-systems to defend against the various chemical and biological warfare threats facing U.S. forces. No single technology or approach is likely to be effective. Consequently, detection and identification of CB threats, individual and collective protection, decontamination and medical countermeasures play important, complementary roles in countering chemical and biological threats. Since Operation Desert Storm, the CBDP effectively developed and fielded new or improved capabilities that address shortfalls identified during that war. A few examples include the fielding of the Biological Integrated Detection System (BIDS), replacement of chemical alarms with the Automatic Chemical Agent Detector and Alarm (ACADA), and procurement of new, lightweight chemical protective suits for the entire force. Significant advances in research promise to yield continuous capability improvements over the next decade. These include: medical countermeasures against chemical and biological agents; improved, lightweight chemical detectors; advanced biological identification and diagnosis capabilities; improved decontamination capabilities; and advanced warning systems that provide near real-time hazard analysis and forecasting capabilities. Additionally, a Modeling and Simulation (M&S) commodity area was established to develop common use chemical and biological models and simulations. These capabilities will continue to ensure that U.S. forces are the best-equipped forces in the world to survive, fight, and win in a chemical or biological contaminated environment. ANNA JOHNSON-WINEGAR, PH.D. DEPUTY ASSISTANT TO THE SECRETARY OF DEFENSE FOR CHEMICAL AND BIOLOGICAL DEFENSE
Threat & Response ■ Global Threat......................................................................................2 ■ Support to Joint Vision 2020 ..............................................................4 ■ Integrated Approach to Counter the Threat .........................................6 Contamination Avoidance ■ ACADA................................................................................................8 ■ Artemis ............................................................................................10 ■ BIDS.................................................................................................12 ■ ICAM ................................................................................................14 ■ JBPDS..............................................................................................16 ■ JCAD................................................................................................18 ■ JSLNBCRS........................................................................................20 ■ JSLSCAD..........................................................................................22 ■ JWARN.............................................................................................24 ■ NBCRS Modifications........................................................................26 Protection (Individual/Collective) ■ CBPS................................................................................................28 ■ CP DEPMEDS ...................................................................................30 ■ CPS Backfit/SCPE.............................................................................32 ■ JPACE/JSAM ....................................................................................34 ■ JSGPM .............................................................................................36 ■ JSLIST/JSLIST P3I ............................................................................38 ■ JTCOPS............................................................................................40 Medical ■ JBAIDS.............................................................................................42 ■ Medical Vaccines..............................................................................44 ■ Medical CB Products ........................................................................46 ■ Medical Pretreatments .....................................................................48 ■ Medical CB Therapeutics and Diagnostics ........................................50 Decontamination ■ JSFXD ..............................................................................................52 ■ JSSED ..............................................................................................54 ■ MDS.................................................................................................56 ■ Sorbent ............................................................................................58 Modeling & Simulation ■ Modeling & Simulation .....................................................................60 Science & Technology ■ Science & Technology ......................................................................62 ■ ACTDs ..............................................................................................64 Doctrine & Training ■ Joint Service CB Defense Doctrine and Training ...............................66 Management ■ Joint Management Structure ............................................................68 ■ Joint Management Organizations (JSIG/JSMG) .................................70 ■ Service Proponent Structure Army .............................................................................................72 Air Force .......................................................................................73 Navy .............................................................................................74 Marine Corps ................................................................................75 ■ CBDP Funding ..................................................................................76 CB Defense Resources ■ Acronyms.........................................................................................78 ■ Points of Contact ..............................................................................80 ■ CB Defense on the Web ............................................Inside Back Cover Table of Contents 1
Page 4 and 5: Global Threat 2 A Dangerous World
Page 6 and 7: Support to Joint Vision 2020 4 Domi
Page 8 and 9: Integrated Approach to Counter the
Page 10 and 11: ACADA 8 Automatic Chemical Agent De
Page 12 and 13: Artemis 10 Artemis formerly Joint S
Page 14 and 15: BIDS 12 Biological Integrated Detec
Page 16 and 17: ICAM 14 Improved Chemical Agent Mon
Page 18 and 19: JBPDS 16 Joint Biological Point Det
Page 20 and 21: JCAD 18 Joint Chemical Agent Detect
Page 22 and 23: JSLNBCRS 20 Joint Service Lightweig
Page 24 and 25: JSLSCAD 22 Joint Service Lightweigh
Page 26 and 27: JWARN 24 Joint Warning and Reportin
Page 28 and 29: NBCRS Modifications 26 NBC Reconnai
Page 30 and 31: CBPS 28 Chemical Biological Protect
Page 32 and 33: CP DEPMEDS 30 Chemically Protected
Page 34 and 35: CPS Backfit/SCPE 32 Collective Prot
Page 36 and 37: JPACE/JSAM 34 Joint Protective Airc
Page 38 and 39: JSGPM 36 Joint Service General Purp
Page 40 and 41: JSLIST/JSLIST P3I 38 Joint Service
Page 42 and 43: JTCOPS 40 Joint Transportable Colle
Page 44 and 45: JBAIDS 42 Joint Biological Agent Id
Page 46 and 47: Medical Vaccines 44 Medical Biologi
Page 48 and 49: Medical CB Products 46 Medical CW/B
Page 50 and 51: Medical Pretreatments 48 Chemical W
Page 52 and 53:
Medical CB Therapeutics and Diagnos
Page 54 and 55:
JSFXD 52 Joint Service Fixed Site D
Page 56 and 57:
JSSED 54 Joint Service Sensitive Eq
Page 58 and 59:
MDS 56 Modular Decontamination Syst
Page 60 and 61:
Sorbent 58 Sorbent Decontamination
Page 62 and 63:
Modeling and Simulation 60 Modeling
Page 64 and 65:
Science & Technology 62 Lead Servic
Page 66 and 67:
ACTDs 64 What is an ACTD? Advanced
Page 68 and 69:
Joint Service CB Defense Doctrine a
Page 70 and 71:
Joint Management Structure 68 The N
Page 72 and 73:
JSIG/JSMG Management 70 Joint Servi
Page 74 and 75:
Army CBD Proponent Structure 72 Arm
Page 76 and 77:
Navy CBD Proponent Structure 74 Nav
Page 78 and 79:
Funding 76 FY01 CBDP Funding Distri
Page 80 and 81:
Acronyms 78 AA Abbreviate Analysis
Page 82 and 83:
Points of Contact 80 Office of the
Page 84 and 85:
Points of Contact 82 Joint Service
Page 86 and 87:
Points of Contact 84 Joint Science
Page 88:
Requests for this document should b
show all

Joint Service Chemical & Biological Defense Program Overview ...

Create successful ePaper yourself

Delete template?

Save as template?